title: Effect of apolipoprotein polymorphisms in renal transplant recipients.
abstract: Cardiovascular disease (CVD) is the main cause of mortality among long-term renal transplant recipients (RTR). On the other hand, allograft chronic nephropathy is the primary cause of graft loss among long-term RTR. Hyperlipidemia is a predisposing factor for both conditions. Polymorphisms of the apolipoproteins modulate lipid metabolism. The aim of the study was to evaluate the effect of apo A-I, apo A-IV and apo C-III genotypes on the long-term results of renal transplantation. Clinical assessment (renal allograft and patient survival) and genotyping for apo A-I (+83C/T), apo C-III (Sst I), and apo A-IV (Thr347Ser and Gln360His) polymorphisms were evaluated in 516 kidney transplant patients and correlated with the clinical evolution over 12 months. The distribution of the apo A-I (+83C/T) polymorphisms was: CC 91.9%, CT 7.9%, and TT 0.2%. The apo C-III genotype showed: S1S1 84.4%, S1S2 15.2%, and S2S2 0.4%. The apo A-IV (Pvu II) polymorphism was: GG 82%, GT 18%, and 0% TT. Finally, the frequency of apo A-IV (Hinf I) polymorphism was: AA 69%, AT 27%, and TT 4%. The frequency of polymorphisms was similar between men and women. In conclusion, there was no significant influence of apolipoprotein polymorphisms on renal and patient survival.
authors.affiliation: Renal Transplant Unit, Hospital Clinic, University of Barcelona, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Cofan
authors.forename: F
authors.initials: F
authors.lastname: Cofan
authors.forename: B
authors.initials: B
authors.lastname: Campos
authors.forename: E
authors.initials: E
authors.lastname: Casals
authors.forename: D
authors.initials: D
authors.lastname: Zambon
authors.forename: E
authors.initials: E
authors.lastname: Ros
authors.forename: J M
authors.initials: JM
authors.lastname: Campistol
authors.forename: F
authors.initials: F
authors.lastname: Oppenheimer
mesh_terms: D016632:Apolipoprotein A-I / Q000235:genetics; D053305:Apolipoprotein C-III; D001053:Apolipoproteins / Q000235:genetics*; D001054:Apolipoproteins A / Q000235:genetics; D001056:Apolipoproteins C / Q000235:genetics; D005838:Genotype; D006801:Humans; D016030:Kidney Transplantation / Q000401:mortality / Q000502:physiology*; D011110:Polymorphism, Genetic; D016019:Survival Analysis
chemical_list: D016632:Apolipoprotein A-I; D053305:Apolipoprotein C-III; D001053:Apolipoproteins; D001054:Apolipoproteins A; D001056:Apolipoproteins C; C022205:apolipoprotein A-IV